News & Analysis as of

Intellectual Property law-news Labor & Employment

Read Intellectual Property Law updates, alerts, news, and legal analysis from leading lawyers and law firms:
Akerman LLP

Hard “G” Beats Soft “J”: GASPER ROOFING Escapes JASPER Confusion Block

Akerman LLP on

A USPTO Examining Attorney refused to register GASPER ROOFING, finding it confusingly similar to the already-registered JASPER CONTRACTORS—same services, similar letter strings, case closed. Then Applicant appealed. In In re...more

Adler Pollock & Sheehan P.C.

AI, Patent Strategy, and What Actually Drives Outcomes in 2026 – Part 2

Part 1 of this series focused on diligence and opinions. Patent prosecution is undergoing the same transition: AI has dramatically improved efficiency, but strategic value increasingly comes from understanding where...more

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Intellectual Property as a Value Driver and Risk Factor in Life Sciences Venture Investment: A Ten-Issue Due Diligence Framework

For venture capital investors in the life sciences sector, intellectual property (IP) is not merely a legal checklist item, it can be a primary determinant of company value, competitive insulation, and exit options....more

Offit Kurman

“Alright, Alright, Alright,” — Taylor’s Version. Taylor Swift follows Matthew McConnaughey’s Novel Approach to Using Trademark...

Offit Kurman on

Ever eager to retain control over her masters and ensure that she “never goes out of style,” Taylor Swift is the latest public figure looking toward registration of sensory trademarks to protect her name and likeness in a...more

McDonnell Boehnen Hulbert & Berghoff LLP

Enviro Tech Chemical Services, Inc. v. Safe Foods Corp. (Fed. Cir. 2026)

While the Supreme Court established a rather definitive standard (“reasonable certainty by a person having ordinary skill in the art”) for determining indefiniteness under 35 U.S.C. § 112(b) in Nautilus, Inc. v. Biosig...more

Venable LLP

Spotlight On: Prolia® / Xgeva® (denosumab) / Jubbonti® / Wyost® (denosumab-bbdz) / Ospomyv® / Xbryk® (denosumab-dssb) / Stoboclo®...

Venable LLP on

Denosumab Challenged Claim Types in Litigation: Claims are counted in each litigation, so claims from the same patent challenged in multiple litigations are counted more than once. Within each litigation a claim is counted...more

Brooks Kushman P.C.

Foreign Filing Licenses in a Global Market

Brooks Kushman P.C. on

Innovation today rarely sits within a single building or even a single country. Multinational teams collaborate across borders, and ideas move faster than the rules designed to regulate them. Yet when it comes to patent...more

Schwabe, Williamson & Wyatt PC

Latest Federal Court Cases: Enviro Tech Chem. Servs., Inc. v. Safe Foods Corp.

Enviro Tech Chem. Servs., Inc. v. Safe Foods Corp., Appeal No. 2024-2160 (Fed. Cir. May 4, 2026) In its only precedential patent opinion last week, the Federal Circuit affirmed a district court’s determination that asserted...more

Venable LLP

Spotlight On: Actemra® (tocilizumab) / Tofidence™ (tocilizumab-bavi) / Tyenne® (tocilizumab-aazg) / Avtozma® (tocilizumab-anoh) -...

Venable LLP on

Tocilizumab Challenged Claim Types in IPRs: Claims are counted in each IPR, so claims from the same patent challenged in multiple IPRs are counted more than once. Within each IPR, claims are counted only once, whether they...more

Goodwin

Third Circuit Affirms Denial of Stelara Biosimilar Injunction

Goodwin on

As previously reported, litigation between Johnson & Johnson and Janssen (“J&J”) and Samsung Bioepis (“Samsung”) involving Samsung’s Stelara biosimilar, PYZCHIVA (ustekinumab-ttwe) (previously known as SB17), was resolved via...more

Venable LLP

Spotlight On: Enbrel® (etanercept) / Erelzi® (etanercept-szzs) / Eticovo® (etanercept-ykro) - May 2026

Venable LLP on

Etanercept Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple...more

ArentFox Schiff

Look What You Made Me Do: Taylor Swift’s Trademark Strategy Takes Aim at AI

ArentFox Schiff on

On April 24, Taylor Swift’s company, TAS Rights Management, filed three new trademark applications with the US Patent and Trademark Office (USPTO) in what appears to be an effort to safeguard her identity against the rising...more

Fish & Richardson

Enforcing SEPs at the ITC: Injunctive Relief Globally

Fish & Richardson on

The number of venues for enforcing standard essential patents (SEPs) continues to increase all over the world. Here, we explain the main drivers behind why patent owners may want to choose the U.S. International Trade...more

Venable LLP

Spotlight On: Herceptin® (trastuzumab) / Ogivri® (trastuzumab-dkst) / Herzuma® (trastuzumab-pkrb) / Ontruzant® (trastuzumab-dttb)...

Venable LLP on

Trastuzumab Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple...more

WilmerHale

The ITC’s Proposed Financial Interest Disclosure Rule: Implications for Section 337 Practice

WilmerHale on

On April 30, 2026, the U.S. International Trade Commission proposed amendments to 19 C.F.R. Part 210 that would require all nongovernment parties in Section 337 Investigations to disclose entities with an ownership or...more

Hogan Lovells

China’s SPC clarifies the Limits of Design Patents vs Trademarks: Key takeaways from the Puma cases

Hogan Lovells on

The Puma Supreme People’s Court case confirms that, where a design patent is challenged on the ground that it conflicts with earlier trademark rights, Chinese courts will assess the conflict by examining whether a design...more

ALTO Litigation

April Trade Secrets Litigation Brief: AI Cardiology Dispute, Aviation Engineer’s Guilty Plea, and Insurance Exec Accused of Data...

ALTO Litigation on

Trade secret litigation often turns on fast-moving disputes over information, competition, and control. Each month, we highlight notable rulings, verdicts, and enforcement actions shaping trade secret risk and litigation...more

Baker Donelson

The Invisible Insider: How AI Agents Enable Undetectable Trade Secret Theft – and What Companies Must Do Now

Baker Donelson on

Key Takeaways - AI agents can harvest, synthesize, and exfiltrate trade secrets through more than a dozen evasion techniques that generate no conventional security alert....more

Foley Hoag LLP

The DTSA Turns Ten: What a Decade of Litigation Tells Us

Foley Hoag LLP on

May 11, 2026 marks the tenth anniversary of the Defend Trade Secrets Act. The DTSA created a federal civil cause of action for trade secret misappropriation, giving companies across the country a powerful new tool to protect...more

Alston & Bird

Insurance Insights | Artificial Intelligence, Duty to Defend, the Patent Frontier

Alston & Bird on

Welcome to the latest issue of Insurance Insights, a gathering of notable legal developments and trends relevant to the insurance industry. In this issue, we cover five things to know about artificial intelligence, an...more

ArentFox Schiff

Tenth Circuit Affirms Fair Use of Archival Footage in Tiger King Copyright Dispute

ArentFox Schiff on

The saga of Joe Exotic has generated no shortage of legal drama. And a recent Tenth Circuit decision adds an important new chapter — one with significant implications for copyright holders and content creators alike across...more

ArentFox Schiff

USPTO Extends Fast-Track Appeals Pilot Program With Four-Month Decision Target

ArentFox Schiff on

In a Federal Register notice published May 6, the USPTO extended the program through May 6, 2028, with one principal change: the Board now aims to issue a decision within four months from the date the appeal enters the...more

Venable LLP

Spotlight On: Humira® (adalimumab) / Amjevita™ (adalimumab-atto) / Cyltezo® (adalimumab-adbm) / Hyrimoz™ (adalimumab-adaz) /...

Venable LLP on

Adalimumab Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple...more

BakerHostetler

[Podcast] Innovation Under Lock: Protecting IP Assets

BakerHostetler on

Intellectual property is one of the – if not the – greatest assets a business can own. Innovative companies need to carefully identify and protect their IP assets in order to maximize their value over their terms of...more

Venable LLP

Spotlight On: Rituxan® (rituximab) / Truxima® (rituximab-abbs) / Ruxience® (rituximab-pvvr) / Riabni™ (rituximab-arrx) - May 2026

Venable LLP on

Rituximab Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple...more

43,843 Results
 / 
View per page
Page: of 1,754

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide